Forthcoming Issue

Peer review articles planned or manuscripts submitted for peer review approval and publication in the forthcoming issues.

Online First

Online First articles have been peer reviewed, accepted for publication and published online; they have not yet been assigned to a journal issue. When an article is published in a journal issue with the assigned page number, it will be removed from the ‘Forthcoming Issue’ page.

Online First articles are copyedited by the science editors and the editorial production team; typeset, proofread and approved by the author(s) before publication. We aim to post each article within six weeks of acceptance and within two weeks after final proofreading approval by the author. Online First articles are in searchable full text, with the initial online publication date included in the final print version.

Articles appearing on the ‘Forthcoming Issue’ page are in the order of the Journal Editorial Sections.  You may also view the abstract by clicking on the article link.

Subscribe now to the print or PDF copy of GaBI Journal to view full information of the following manuscripts*.

Editor’s Letter

Unmet potential of Generics and Biosimilars to reduce healthcare costs / Professor Philip D Walson, MD

Editor’s introduction to the initial issue of the eighth volume of GaBI Journal / Professor Philip D Walson, MD

Original Research

Pricing of oral generic cancer medicines in Europe; findings and implications / Brian Godman, BSc, PhD; Andrew Hill; Professor Steven Simoens, MSc, PhD; Amanj Kurdi, BSc, PhD; Jolanta Gulbinovič, MD, PhD; Antony P Martin; Angela Timoney; Dzintars Gotham, MBBS; Janet Wale; Tomasz Bochenek, MD, PhD; Celia C Rothe; Iris Hoxha; Admir Malaj; Christian Hierländer; Robert Sauermann, MD; Wouter Hamelinck; Zornitza Mitkova; Guenka Petrova, MPharm, MEcon, PhD, DSci; Ott Laius; Catherine Sermet; Irene Langer; Gisbert Selke; John Yfantopoulos; Roberta Joppi; Arianit Jakupi; Elita Poplavska, PhD; Ieva Greiciute-Kuprijanov; Patricia Vella Bonanno1, BPharm, MSc, PhD; JF (Hans) Piepenbrink; Vincent de Valk; Carolin Hagen, Anne Marthe Ringerud, Robert Plisko, Magdalene Wladysiuk, Vanda Marković-Peković, PhD; Nataša Grubiša; Tatjana Ponorac; Ileana Mardare; Tanja Novakovic; Mark Parker; Jurij Fürst; Dominik Tomek, PharmD, MSc, PhD; Mercè Obach Cortadellas; Corinne Zara; Maria Juhasz-Haverinen, MScPharm; Peter Skiold; Stuart McTaggart; Alan Haycox, PhD

Pharmacy Chain Drives Choice among Manufacturers of Generic Drugs in the US Medicare Population / Steven Kozlowski, MD, Ellen Tworkoski, MS, MPhil, Carmen Dekmezian, MS, Yanchang Zhang, MPH, Natasha Flowers, BA, Alvin So, MS, Andreas M Schick, PhD, Michael Wernecke, BA, Thomas MaCurdy, PhD, and Jeffrey A Kelman, MD, MMSc

Review Article

Are there biosimilar orphan drugs for Gaucher disease? An overview in Mexico / G Castañeda-Hernández, PhD; L Carbajal-Rodríguez, MD; M Cerón-Rodríguez, MD; Professor LC Correa- González, MD; A Esquivel-Aguilar, PhD; SJ Franco-Ornelas, MD; JE García Ortiz, PhD; CM Hernández- Guadarrama, MD; JI Navarrete-Martínez, MD; Y Santillán-Hernández, MD; E Terreros-Muñoz, MD

An Ever-Evolving Landscape: an Update on the Rapidly Changing Regulatory and Reimbursement of Biosimilars in Canada / Eric C K Siu, MSc, PhD; Anne Tomalin, BA, BSc; Kevin West, BA; Sandra Anderson, BA, MBA; George Wyatt, BSc, MBA

Overview of non-innovator biological products in India / GR Soni, PhD


Biosimilars: considerations in light of the Italian legal framework / Enrico Adriano Raffaelli; Fausto Massimino, Italy

Meeting Report

2nd MENA Stakeholder Meeting on Biosimilars 2018 – Report / Andrea Laslop, MD; Jian Wang, PhD; Robin Thorpe, PhD, FRCPath

1st ASEAN Overview Workshop on GMP for Biologicals/Biosimilars 2018 – Report / Elwyn Griffiths, PhD, DSc, Professor Chong Hock Sia

Special Report

Patent expiry dates for biologicals: 2018 update / Michelle Derbyshire, PhD, GaBI Online Editor; Sophie Shina, MSc, GaBI Journal Editor

Pharma News

Top developments in biosimilars during 2018 / Sophie Shina, MSc, GaBI Journal Editor

Abstracted Scientific Content

Regulatory requirements for the acceptance of foreign comparator products in the participants of the International Generic Drug Regulators ProgrammeUS generic prescription drug markets 2004‒2016 / Dr Alfredo García Arieta, Spain

Escalating prices of generic drugs targeted by US anti-gouging legislation / Sophie Shina, MSc, GaBI Journal Editor

Click here for more details on the educational series.

Contact us for an updated list of editorial topics in forthcoming issues.

*Editorial content may differ from final version of manuscript published in print.

Source URL:

Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048